Prostamax | Prostate & Prostate Tissue

Prostamax is a short peptide studied specifically in connection with the prostate and age-related changes in prostate tissue. Researchers have explored how it may influence prostate-cell activity, tissue regulation, and cellular processes involved in maintaining normal prostate structure and function. The available evidence is primarily laboratory and animal research rather than controlled human studies.

In scientific terms, Prostamax is a synthetic tetrapeptide with the amino-acid sequence Lys-Glu-Asp-Pro (KEDP). It belongs to the family of short peptide bioregulators studied for tissue-specific activity. Research has examined prostate tissue models as well as cellular processes involving chromatin structure and gene regulation, but its effects in humans have not been established in controlled clinical trials.

Product contents: Contains 30 mg total in 3 mL of liquid (10 mg/mL).